Efficacy and Safety Evaluation of Osilodrostat in Cushing's Disease (Q64151404)
Jump to navigation
Jump to search
clinical trial
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Efficacy and Safety Evaluation of Osilodrostat in Cushing's Disease |
clinical trial |
Statements
LINC-4 (English)
0 references
A Phase III, Multi-center, Randomized, Double-blind, 48 Week Study With an Initial 12 Week Placebo-controlled Period to Evaluate the Safety and Efficacy of Osilodrostat in Patients With Cushing's Disease (English)
0 references
3 October 2016
0 references
1 January 2021
0 references
69
0 references
18 year
0 references
75 year
0 references